Financhill
Sell
10

NGRRF Quote, Financials, Valuation and Earnings

Last price:
$86.08
Seasonality move :
-20.57%
Day range:
$86.08 - $86.08
52-week range:
$71.86 - $106.40
Dividend yield:
2.39%
P/E ratio:
19.49x
P/S ratio:
1.12x
P/B ratio:
4.62x
Volume:
2
Avg. volume:
181
1-year change:
-12.38%
Market cap:
$1.1B
Revenue:
$987.4M
EPS (TTM):
$4.42
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $450.5M $491.5M $646.1M $903.1M $987.4M
Revenue Growth (YoY) -- 9.1% 31.45% 39.78% 9.34%
 
Cost of Revenues $342.4M $369.4M $520M $693M $796.6M
Gross Profit $108.1M $122.1M $126M $210.1M $190.8M
Gross Profit Margin 23.99% 24.85% 19.51% 23.27% 19.32%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.3M $7.6M $10.8M $14.3M $14.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $56.1M $59.3M $72.3M $94.5M $93.3M
Operating Income $52M $62.9M $53.7M $115.6M $97.5M
 
Net Interest Expenses $5.9M $7.8M $8.8M $11.3M $17.7M
EBT. Incl. Unusual Items $41.6M $43.1M $45.2M $107.3M $75.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.6M $15.3M $9.7M $25.6M $19.2M
Net Income to Company $47.5M $50.9M $54.1M $118.6M $93.3M
 
Minority Interest in Earnings -$5.5M -$6.7M -- -- --
Net Income to Common Excl Extra Items $28.5M $21.1M $35.5M $81.6M $56.4M
 
Basic EPS (Cont. Ops) $2.51 $1.85 $2.99 $5.94 $4.19
Diluted EPS (Cont. Ops) $2.51 $1.85 $2.97 $5.90 $4.18
Weighted Average Basic Share $11.4M $11.4M $11.9M $13.8M $13.5M
Weighted Average Diluted Share $11.4M $11.4M $12M $13.8M $13.5M
 
EBITDA $69.2M $76.1M $83.6M $154M $133.3M
EBIT $47.7M $51.4M $54.5M $119.1M $95.3M
 
Revenue (Reported) $450.5M $491.5M $646.1M $903.1M $987.4M
Operating Income (Reported) $52M $62.9M $53.7M $115.6M $97.5M
Operating Income (Adjusted) $47.7M $51.4M $54.5M $119.1M $95.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $123.2M $166.2M $231.5M $255.1M $267.2M
Revenue Growth (YoY) -- 34.85% 39.28% 10.19% 4.75%
 
Cost of Revenues $87.8M $129.2M $172M $204.6M $207.7M
Gross Profit $35.5M $37M $59.5M $50.5M $59.4M
Gross Profit Margin 28.77% 22.24% 25.69% 19.79% 22.24%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $20.1M $20.6M $20.5M $23.7M $34.3M
Operating Income $15.4M $16.4M $39M $26.8M $25.2M
 
Net Interest Expenses $2.5M $2M $3.3M $5.3M $4.6M
EBT. Incl. Unusual Items $11.9M $13.8M $36.1M $18.8M $20.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.3M $3.9M $10.2M $5.1M $6.2M
Net Income to Company $16.2M $15.3M $36.5M $24M $25.9M
 
Minority Interest in Earnings -$1.9M -- -- -- --
Net Income to Common Excl Extra Items $8.7M $9.9M $26M $13.7M $14M
 
Basic EPS (Cont. Ops) $0.76 $1.13 $1.88 $1.02 $1.06
Diluted EPS (Cont. Ops) $0.76 $0.94 $1.87 $1.02 $1.06
Weighted Average Basic Share $11.4M $13.8M $13.8M $13.4M $13.3M
Weighted Average Diluted Share $11.4M $13.8M $13.8M $13.4M $13.3M
 
EBITDA $20.7M $22.8M $48.1M $33.7M $36M
EBIT $14.6M $15.9M $39.6M $24.4M $25.7M
 
Revenue (Reported) $123.2M $166.2M $231.5M $255.1M $267.2M
Operating Income (Reported) $15.4M $16.4M $39M $26.8M $25.2M
Operating Income (Adjusted) $14.6M $15.9M $39.6M $24.4M $25.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $589M $848.7M $985.1M $1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $443M $667.7M $759.2M $791.5M
Gross Profit -- $146M $181M $226M $235.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- $86.2M $80.3M $132.1M $131.6M
Operating Income -- $59.8M $100.7M $93.9M $104.2M
 
Net Interest Expenses $5.9M $8.2M $10.5M $16.4M $18.9M
EBT. Incl. Unusual Items -- $42M $97.6M $75.9M $82.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $15.9M $22.6M $17.9M $23.9M
Net Income to Company -- $48.3M $104.5M $97.6M $102.4M
 
Minority Interest in Earnings -$4.6M -$5.5M -- -- --
Net Income to Common Excl Extra Items -- $20.6M $75M $58.1M $59M
 
Basic EPS (Cont. Ops) -- $2.06 $5.49 $4.28 $4.44
Diluted EPS (Cont. Ops) -- $1.86 $5.44 $4.26 $4.42
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $78.1M $142.6M $128.9M $147.9M
EBIT -- $50.9M $108.4M $93.7M $105.1M
 
Revenue (Reported) -- $589M $848.7M $985.1M $1B
Operating Income (Reported) -- $59.8M $100.7M $93.9M $104.2M
Operating Income (Adjusted) -- $50.9M $108.4M $93.7M $105.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $361.4M $459.1M $663.4M $749M $788.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $267.6M $341.3M $508M $572.4M $590.8M
Gross Profit $93.9M $117.8M $155.4M $176.6M $198.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $59.6M $76.5M $65.3M $101.5M $118.1M
Operating Income $34.3M $41.4M $90.1M $75.1M $79.9M
 
Net Interest Expenses $5.9M $6.3M $8M $13.1M $14.3M
EBT. Incl. Unusual Items $36M $35.2M $87.6M $57M $64.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.3M $9.4M $22.2M $14.6M $19.3M
Net Income to Company $43.6M $41M $91.4M $70.4M $79.5M
 
Minority Interest in Earnings -$4.6M -$3.3M -- -- --
Net Income to Common Excl Extra Items $22.7M $22.6M $65.4M $42.4M $45M
 
Basic EPS (Cont. Ops) $1.99 $2.24 $4.75 $3.13 $3.38
Diluted EPS (Cont. Ops) $1.99 $2.04 $4.71 $3.11 $3.37
Weighted Average Basic Share $34.1M $36.6M $41.3M $40.6M $40M
Weighted Average Diluted Share $34.1M $36.8M $41.6M $41M $40M
 
EBITDA $60.3M $62.5M $121.6M $97.4M $112.1M
EBIT $42.3M $42M $95.9M $71.3M $81.2M
 
Revenue (Reported) $361.4M $459.1M $663.4M $749M $788.9M
Operating Income (Reported) $34.3M $41.4M $90.1M $75.1M $79.9M
Operating Income (Adjusted) $42.3M $42M $95.9M $71.3M $81.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $49M $132.5M $120.7M $118.1M $121.7M
Short Term Investments $1.4M $2M $2.7M $6.1M $14.6M
Accounts Receivable, Net $90M $90.9M $130.6M $168.2M $201.7M
Inventory $10.1K -- -- $283.1K $1.1K
Prepaid Expenses $457K $830.2K $990.7K $846.1K $952.9K
Other Current Assets $1.1K -$2.5K $1.1K $2.2K --
Total Current Assets $176M $258.7M $294.1M $346.6M $391.3M
 
Property Plant And Equipment $69.5M $71.5M $41.2M $40.3M $43.5M
Long-Term Investments -- -- -- -- --
Goodwill $114.7M $117.9M $185M $217.3M $244.1M
Other Intangibles $10.1M $13.5M $55.9M $42.7M $52.8M
Other Long-Term Assets -$1.1K -$1.2K $2.3K -$2.2K -$1.1K
Total Assets $383.1M $475.8M $594.3M $663.9M $751.5M
 
Accounts Payable $18.2M $27.3M $20.9M $16.4M $19.8M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $13.6M $14.7M $22M $23.4M $22.2M
Other Current Liabilities $12.3M $5.3M $19.7M $21.7M $15.6M
Total Current Liabilities $241.9M $143.1M $185M $192.5M $186.1M
 
Long-Term Debt $273.3K $206.8M $210.7M $219.9M $296.9M
Capital Leases -- -- -- -- --
Total Liabilities $316M $418.5M $484.6M $486.3M $551.3M
 
Common Stock $56K $14M $15.6M $14.8M $15.2M
Other Common Equity Adj -- -- -- -- --
Common Equity $56.3M $53.9M $109.6M $177.6M $200.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $10.9M $3.4M -- -- --
Total Equity $67.1M $57.2M $109.6M $177.6M $200.2M
 
Total Liabilities and Equity $383.1M $475.8M $594.3M $663.9M $751.5M
Cash and Short Terms $50.4M $134.5M $123.4M $124.2M $136.3M
Total Debt $140.4M $224.6M $237.6M $232.2M $303.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $127.2M $88.2M $97M $157.5M
Short Term Investments -- $6.4M $10.3M $14M $6.3M
Accounts Receivable, Net -- $92.1M $175.6M $191.9M $226.7M
Inventory -- $38.3K $229K $253K --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $12.9M $16.2M $16.9M $13.4M
Total Current Assets -- $286.2M $334.7M $372.5M $463.7M
 
Property Plant And Equipment -- $69.3M $68M $64.5M $60.9M
Long-Term Investments -- -- -- -- --
Goodwill -- $115.8M $215M $263M $244.4M
Other Intangibles -- $10.4M $16.3M $14.7M $25.3M
Other Long-Term Assets -- $180.9K $852.2K $2.4M $723.8K
Total Assets -- $495.2M $652.7M $733.5M $817M
 
Accounts Payable -- $12.1M $20.7M $16.5M $20.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $15.5M $21.3M $23.1M $20.5M
Other Current Liabilities -- $7.7M $30.3M $31.8M $14.5M
Total Current Liabilities -- $142.8M $194.6M $194.7M $186.7M
 
Long-Term Debt -- $188.6M $201.5M $273.4M $311.3M
Capital Leases -- -- -- -- --
Total Liabilities -- $395.9M $477.8M $541.6M $568.8M
 
Common Stock -- $13.4M $13.5M $14.6M $15.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $99.3M $174.9M $192M $248.2M
 
Total Liabilities and Equity -- $495.2M $652.7M $733.5M $817M
Cash and Short Terms -- $133.6M $98.5M $111M $163.8M
Total Debt -- $209.5M $212.9M $280.4M $313.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $47.5M $50.9M $54.1M $118.6M $93.3M
Depreciation & Amoritzation $21.5M $24.7M $29.1M $34.9M $38M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $45.8M $82.5M $52M $86.8M $84.1M
 
Capital Expenditures $3.5M $4.1M $3.2M $4.4M $7.4M
Cash Acquisitions -$3.2M -$8.9M -$59.3M -$42.6M -$58.8M
Cash From Investing -$9M -$11.6M -$62.5M -$46.4M -$69M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $6.6M $205.1M $39.2M $25.9M $77.5M
Long-Term Debt Repaid -$10.6M -$181.2M -$17.7M -$13.9M -$10M
Repurchase of Common Stock -- -- -- -$10.6M -$32.2M
Other Financing Activities $1.9M $458K $3.9M -- $2.2K
Cash From Financing -$19.2M $4.2M $15.4K -$30.4M -$7.2M
 
Beginning Cash (CF) $25.4M $44.3M $122.1M $100.2M $111.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $17.6M $75.1M -$10.4M $10M $7.9M
Ending Cash (CF) $43.4M $117.8M $112.4M $108.8M $116.7M
 
Levered Free Cash Flow $42.3M $78.4M $48.8M $82.4M $76.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $16.2M $15.3M $36.5M $24M $25.9M
Depreciation & Amoritzation $6.9M $6.6M $7.6M $9.3M $10.7M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $22.6M $15.5M $29.9M $28.3M $41.7M
 
Capital Expenditures $647.5K $790.8K $708.2K $2.5M $1.1M
Cash Acquisitions -$1.2M $77K $106.5K $368K -$1.3M
Cash From Investing -$1.8M -$713.9K -$599.3K -$1.4M -$1.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $252.6K -- $3.3M $3.4M $253.2K
Long-Term Debt Repaid $36.3K -$2.5M -$4.2M -$4.7M -$340.5K
Repurchase of Common Stock -$3.3M -- -$295.2K -$14.5M --
Other Financing Activities $1M -$3.4M $89.1K $1.1K --
Cash From Financing -$6.8M -$9.1M -$9M -$26.4M -$13.4M
 
Beginning Cash (CF) $71.1M $118.3M $69.3M $96.4M $125.6M
Foreign Exchange Rate Adjustment -$969.2K $807.9K -$697.5K -$491.4K -$833K
Additions / Reductions $14M $5.6M $20.3M $462.3K $26.9M
Ending Cash (CF) $86.8M $122.1M $83.4M $96.2M $154.2M
 
Levered Free Cash Flow $22M $14.7M $29.2M $25.8M $40.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $48.3M $104.5M $97.6M $102.4M
Depreciation & Amoritzation -- $26.2M $33.2M $36.8M $43M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- $41.9M $73M $86M $110.4M
 
Capital Expenditures $2.5M $4.5M $3.2M $6.6M $6.5M
Cash Acquisitions -$5.2M -$8.6M -$93.7M -$56.1M -$16.6M
Cash From Investing -- -$11.7M -$96.9M -$60.4M -$19.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $201.3M $63.7M $67.2M $23.6M
Long-Term Debt Repaid -- -$185.8M -$26.1M -$10.3M -$4.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $598.1K $3.9M -- --
Cash From Financing -- $1.3M $7.1M -$25.4M -$29.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $31.4M -$16.8M $170.3K $61.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- $37.4M $69.8M $79.5M $103.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $43.6M $41M $91.4M $70.4M $79.5M
Depreciation & Amoritzation $18.7M $20.2M $24.3M $26.2M $31.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $65.4M $24.8M $45.8M $45.1M $71.4M
 
Capital Expenditures $2.5M $3M $3M $5.2M $4.2M
Cash Acquisitions -$5.2M -$4.9M -$39.4M -$52.9M -$10.7M
Cash From Investing -$7.7M -$7.9M -$42.3M -$56.4M -$6.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.8M -- $24.6M $65.9M $12.1M
Long-Term Debt Repaid -$304.1K -$4.9M -$13.3M -$9.8M -$4.4M
Repurchase of Common Stock -$3.3M -- -$295.2K -$32.4M --
Other Financing Activities $260.8K $400.9K $341.5K $1.1K --
Cash From Financing -$15M -$17.9M -$10.8M -$5.9M -$28.1M
 
Beginning Cash (CF) $70.3M $359.8M $251.6M $325.4M $376.5M
Foreign Exchange Rate Adjustment -$1.3M $1.4M -$4.9M $1.2M -$804K
Additions / Reductions $42.7M -$984.5K -$7.4M -$17.2M $36.4M
Ending Cash (CF) $156.7M $357.5M $228.4M $310.8M $413.6M
 
Levered Free Cash Flow $62.9M $21.9M $42.8M $39.9M $67.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock